Diabesity Digest is devoted to gathering business and scientific information in the fields of obesity and type 2 diabetes. This website is a comprehensive, unique and useful one-stop information hub covering existing therapeutics as well as research and development of new non-insulin therapies for the treatment of obesity and type 2 diabetes. The strong correlation between these two diseases makes it impossible to address one without the other.
This website is designed to meet the needs of any professional working directly or indirectly in this rapidly evolving field including fund managers, investors, venture capitalists, research scientist, medical practitioners and business/corporate development professionals.
TOPICS COVERED IN THIS WEBSITE:
| DRUG TARGETS | An overview of over 30 validated obesity and type 2 diabetes targets for drugs that are in development, discontinued or on the market as well as illustrations and references to scientific journals for more information. |
| DRUGS IN DEVELOPMENT | A detailed list of over 250 drug development programs for obesity and/or type 2 diabetes including company name, development stage, drug target, indication and comments listed by either drug candidate name, company name or development stage. |
| DRUGS ON THE MARKET | A description of all major approved prescription drugs for obesity and/or type 2 diabetes including tradenames, doses, company(ies), US patent status, FDA and EMEA approval dates and status, indication, elimination half-life and updates. |
| DIABESITY DEALS | A detailed description of over 50 deals in the field of obesity and type 2 diabetes including licensing deals with information on upfront payments, milestones, royalty and other terms including deal updates and acquisitions with information on the transaction value, the transaction details and technology summary. |
| UPCOMING MILESTONES | Important events in the coming year in the field of obesity and type 2 diabetes drug development including expected start and completion dates of clinical trials running through to 2011. |
| DIABESITY COMPANIES | A list of over 140 companies working in the field of obesity and/or type 2 diabetes, directly or through collaborations. This includes drug discovery and development companies, large pharmas and other service companies in this field. |
THIS WEBSITE IS NOT INTENDED FOR PATIENTS.
This website does not cover diabetes or obesity devices, type 1 diabetes, or insulin based products.